Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MDWD

MediWound Ltd

Mar 05 • 04:00PM ET

17.45

-0.15 -0.85 %

Healthcare • Biotechnology • Israel • NASD

Today, 1:15 PMMediWound reports Q4 2025 results with non-GAAP EPS -$0.56, revenue $1.9M, beats EPS, misses revenue, 2025 revenue $17M, 2026–2028 guidance reaffirmed

Peers: AVIR VRCA ABEO CLGN DERM LRMR XCUR MRNS OCGN UBX

| Held by: IWM IZRL IWO VTWO IWC VTWG RSSL QQQS VTHR UWM

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.90	Insider Own	31.20%	Shs Outstand	12.82M	Perf Week	-0.40%
Market Cap	223.97M	Forward P/E	-	EPS next Y	-2.40	Insider Trans	0.00%	Shs Float	8.83M	Perf Month	-3.70%
Enterprise Value	174.21M	PEG	-	EPS next Q	-0.63	Inst Own	53.64%	Short Float	15.21%	Perf Quarter	0.58%
Income	-20.60M	P/S	10.70	EPS this Y	-20.05%	Inst Trans	-0.63%	Short Ratio	13.47	Perf Half Y	5.31%
Sales	20.93M	P/B	4.46	EPS next Y	4.60%	ROA	-24.36%	Short Interest	1.34M	Perf YTD	-5.47%
Book/sh	3.91	P/C	3.79	EPS next 5Y	12.02%	ROE	-48.83%	52W High	22.50 -22.46%	Perf Year	4.18%
Cash/sh	4.60	P/FCF	-	EPS past 3/5Y	4.48% -	ROIC	-35.26%	52W Low	14.14 23.41%	Perf 3Y	43.03%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-5.24% -8.65%	Gross Margin	18.53%	Volatility	3.34% 3.45%	Perf 5Y	-50.34%
Dividend TTM	-	EV/Sales	8.32	EPS Y/Y TTM	34.52%	Oper. Margin	-112.48%	ATR (14)	0.65	Perf 10Y	-66.45%
Dividend Ex-Date	-	Quick Ratio	2.48	Sales Y/Y TTM	6.15%	Profit Margin	-98.43%	RSI (14)	48.28	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.65	EPS Q/Q	75.40%	SMA20	-0.24%	Beta	0.12	Target Price	31.50
Payout	-	Debt/Eq	0.19	Sales Q/Q	24.66%	SMA50	-2.07%	Rel Volume	0.87	Prev Close	17.60
Employees	111	LT Debt/Eq	0.16	Earnings	Mar 05 BMO	SMA200	-5.83%	Avg Volume	99.72K	Price	17.45
IPO	Mar 20, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	13.83% -55.47%	Trades		Volume	87,154	Change	-0.85%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-02-25	Resumed	Oppenheimer	Outperform	$34
May-02-25	Initiated	Alliance Global Partners	Buy	$25
Feb-28-25	Initiated	Craig Hallum	Buy	$39
Jul-16-24	Reiterated	Maxim Group	Buy	$25 → $30
Dec-22-22	Initiated	Maxim Group	Buy	$11
Jul-18-22	Resumed	Oppenheimer	Outperform	$7
Sep-23-20	Initiated	BTIG Research	Buy	$6
Nov-28-16	Initiated	Aegis Capital	Buy	$11
Aug-17-16	Initiated	Wells Fargo	Outperform
Apr-16-14	Initiated	Oppenheimer	Outperform	$25

Today 04:30PM	MediWound Files Annual Report on Form 20-F (GlobeNewswire)
12:35PM	MediWound Ltd. Q4 2025 Earnings Call Summary (Moby)
08:20AM	MediWound (MDWD) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
07:27AM	MediWound: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	MediWound Reports Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
08:05PM	Loading…
Feb-28-26 08:05PM	MediWound Updates NexoBrid Growth, EscharEx Phase III Timeline and BARDA Talks at Oppenheimer Conference (MarketBeat)
Feb-19-26 08:00AM	MediWound to Report Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Feb-17-26 08:00AM	MediWound to Present at Upcoming Investor Conferences (GlobeNewswire)
Jan-12-26 07:00AM	MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference (GlobeNewswire) -7.86%
Dec-10-25 07:00AM	MediWound Reports New Clinical Data Demonstrating NexoBrid's Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries (GlobeNewswire)
Nov-20-25 04:00PM	MediWound Ltd (MDWD) Q3 2025 Earnings Call Highlights: Revenue Surge and Strategic Expansions ... (GuruFocus.com) -5.60%
08:10AM	MediWound (MDWD) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
07:10AM	MediWound: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-14-25 05:30PM	IGC Pharma, Inc. (IGC) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
05:30PM	Loading…
Nov-13-25 05:30PM	RenovoRx, Inc. (RNXT) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
Nov-12-25 05:15PM	Journey Medical Corporation (DERM) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
Nov-10-25 06:00PM	FibroGen (FGEN) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
Nov-06-25 05:55PM	Nektar Therapeutics (NKTR) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
Nov-05-25 07:30AM	MediWound to Report Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-03-25 08:00AM	MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid (GlobeNewswire)
Sep-30-25 08:45AM	MediWound announces $30M registered direct offering (TipRanks)
Sep-29-25 08:37AM	MediWound Announces $30 Million Registered Direct Offering of Ordinary Shares (GlobeNewswire)
Sep-25-25 07:30AM	MediWound Expands Global Reach with Marketing Approval of NexoBrid in Australia (GlobeNewswire)
Sep-02-25 07:30AM	MediWound's NexoBrid to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress (GlobeNewswire)
Aug-20-25 07:30AM	MediWound to Present at the H.C. Wainwright 27th Annual Global Investment Conference (GlobeNewswire)
Aug-14-25 08:10AM	MediWound (MDWD) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
07:10AM	MediWound: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	MediWound Reports Second Quarter 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
Aug-13-25 08:45AM	MediWound Announces New EscharEx Phase II Data Demonstrating Strong Link Between Wound Bed Preparation and Wound Closure in Venous Leg Ulcers (GlobeNewswire)
05:30PM	Loading…
Aug-07-25 05:30PM	Nektar Therapeutics (NKTR) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
Aug-05-25 07:40AM	Stevanato Group (STVN) Q2 Earnings and Revenues Beat Estimates (Zacks)
Aug-04-25 07:30AM	MediWound to Report Second Quarter 2025 Financial Results (GlobeNewswire)
Jul-24-25 08:50AM	Here's What Could Help MediWound (MDWD) Maintain Its Recent Price Strength (Zacks)
May-22-25 03:03AM	MediWound Ltd (MDWD) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Revenue Decline (GuruFocus.com)
May-21-25 08:10AM	MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
07:08AM	MediWound: Q1 Earnings Snapshot (Associated Press Finance)
07:00AM	MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
May-20-25 09:21AM	Earnings To Watch: MediWound Ltd (MDWD) Reports Q1 2025 Result (GuruFocus.com)
May-15-25 05:45PM	BioHarvest Sciences Inc. (BHST) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-14-25 08:25PM	OptiNose (OPTN) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-13-25 05:40PM	Metagenomi (MGX) Reports Q1 Loss, Misses Revenue Estimates (Zacks) +6.81%
07:30AM	MediWound Announces Publication of Phase II EscharEx Data Demonstrating Superiority Over Collagenase in Venous Leg Ulcers (GlobeNewswire)
May-12-25 05:15PM	FibroGen (FGEN) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +6.42%
May-08-25 06:05PM	Theravance Biopharma (TBPH) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
May-05-25 08:00AM	MediWound to Report First Quarter 2025 Financial Results (GlobeNewswire)
Apr-28-25 08:00AM	MediWound to Present New EscharEx Data at Leading Wound Care Conferences (GlobeNewswire)
Mar-21-25 06:31PM	MediWound Ltd (MDWD) Q4 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Mar-20-25 03:01AM	MediWound Ltd (MDWD) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Rising Losses (GuruFocus.com) -6.73%
Mar-19-25 12:10PM	MediWound Ltd. (MDWD) Q4 2024 Earnings Call Transcript (SeekingAlpha) -5.14%
08:10AM	MediWound (MDWD) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:17AM	MediWound: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	MediWound Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Mar-03-25 08:00AM	MediWound to Report Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-25-25 08:00AM	MediWound Announces Phase III CIDS Publication on NexoBrid for Pediatric Burn Care (GlobeNewswire) -7.28%
Feb-24-25 08:00AM	MediWound to Present at the 45th Annual TD Cowen Health Care Conference (GlobeNewswire)
Feb-13-25 10:27AM	MediWound commences Phase III trial for venous leg ulcers treatment (Clinical Trials Arena)
Feb-12-25 07:00AM	MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx for Treatment of Venous Leg Ulcers (GlobeNewswire)
Feb-04-25 08:00AM	MediWound to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference (GlobeNewswire)
Jan-27-25 06:32AM	MediWound (MDWD) Surges 8.5%: Is This an Indication of Further Gains? (Zacks)
Jan-09-25 08:28AM	Mediwound Advances in Enzymatic Therapeutics with Strategic Expansions (TipRanks)
Dec-17-24 08:00AM	MediWound to Host Virtual Key Opinion Leader Event to Discuss EscharEx Phase III VALUE Study in Venous Leg Ulcers and Its Commercial Opportunity on January 8, 2025 (GlobeNewswire)
07:27AM	MediWound Executives Acquire 18,462 Shares, Signaling Confidence in Companys Future (TipRanks)
Nov-27-24 02:02AM	MediWound Ltd (MDWD) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges (GuruFocus.com)
Nov-26-24 08:15AM	MediWound (MDWD) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
07:10AM	MediWound: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	MediWound Reports Third Quarter 2024 Financial Results and Provides Company Update (GlobeNewswire)
Nov-25-24 07:02AM	What To Expect From MediWound Ltd (MDWD) Q3 2024 Earnings (GuruFocus.com) +5.16%
Nov-12-24 08:00AM	MediWound to Report Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-23-24 07:01PM	Rosalind Advisors, Inc. Increases Stake in MediWound Ltd (GuruFocus.com)
Oct-10-24 07:00AM	MediWound Announces Phase II Head-to-Head Study Evaluating EscharEx vs. Collagenase in Patients with Venous Leg Ulcers (GlobeNewswire)
Oct-08-24 08:00AM	MediWound to Participate in the 2024 Maxim Healthcare Virtual Summit (GlobeNewswire)
Sep-03-24 08:00AM	MediWound to Present at the H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire) -7.34%
Aug-16-24 10:33AM	MediWound and Vericel win FDA paediatric label expansion for NexoBrid (Medical Device Network) +6.05%
Aug-15-24 04:15PM	MediWound Announces U.S. Food and Drug Administration Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns (GlobeNewswire)
Aug-14-24 08:15AM	MediWound (MDWD) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
07:18AM	MediWound: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update (GlobeNewswire)
Aug-07-24 10:00AM	MediWound (MDWD) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release (Zacks)
Aug-05-24 07:30AM	MediWound Announces Positive Results from the U.S. NexoBrid Expanded Access Protocol (NEXT) (GlobeNewswire) -6.46%
Aug-02-24 08:00AM	MediWound to Report Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-31-24 09:55AM	Can MediWound (MDWD) Climb 57.49% to Reach the Level Wall Street Analysts Expect? (Zacks)
Jul-30-24 07:13AM	MediWound reinforces wound therapy EscharEx data ahead of Phase III trial (Medical Device Network)
Jul-29-24 08:00AM	MediWound Announces Publication of the EscharEx Phase II ChronEx Study Results for Venous Leg Ulcers (GlobeNewswire)
Jul-16-24 07:30AM	MediWound Announces 16.25 Million Funding from the European Innovation Council Accelerator Program (GlobeNewswire)
Jul-15-24 07:38AM	Mölnlycke® Health Care announces US $15m investment in next-generation enzymatic therapeutics company MediWound Ltd (PR Newswire)
07:38AM	Molnlycke Health Care announces US $15m investment in next-generation enzymatic therapeutics company MediWound Ltd (PR Newswire)
07:00AM	MediWound Announces $25 Million Strategic Private Placement Financing (GlobeNewswire)
May-29-24 02:40PM	A burn treatment company's stock has soared amid Israel's war in Gaza (Quartz) -10.01%
11:53AM	MDWD Stock Earnings: MediWound Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
08:15AM	MediWound (MDWD) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:12AM	MediWound: Q1 Earnings Snapshot (Associated Press Finance)
07:00AM	MediWound Reports First Quarter 2024 Financial Results and Provides Company Update (GlobeNewswire)
May-22-24 08:00AM	MediWound to Report First Quarter 2024 Financial Results (GlobeNewswire)
Apr-25-24 08:00AM	MediWound to Present New Data from EscharEx Phase II Studies at Three Leading Wound Care Conferences (GlobeNewswire)
Apr-17-24 07:24AM	Strength Seen in MediWound (MDWD): Can Its 14.3% Jump Turn into More Strength? (Zacks)
Mar-25-24 09:55AM	Wall Street Analysts See a 76.89% Upside in MediWound (MDWD): Can the Stock Really Move This High? (Zacks)
08:50AM	What Makes MediWound (MDWD) a Good Fit for 'Trend Investing' (Zacks)
Mar-21-24 11:54AM	MDWD Stock Earnings: MediWound Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace)
08:25AM	MediWound (MDWD) Reports Q4 Loss, Tops Revenue Estimates (Zacks)

MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product NexoBrid, is an orphan biologic for eschar removal in severe burns. The company was founded by Lior Rosenberg and Marian Gorecki in January 2000 and is headquartered in Yavne, Israel.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hess Shmuel	Officer	Dec 02 '25	Proposed Sale	17.21	3,693	63,557		Dec 03 07:44 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MDWD

MediWound Ltd

Upgrade your FINVIZ experience